LSV Asset Management
IRWD icon

LSV Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

LSV Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.22M Hold
308,271
– – ﹤0.01% 646
2026
Q2 		$1.3M Hold
308,271
– – ﹤0.01% 642
2026
Q1 		$1.08M Buy
308,271
+299,223
+3,307% +$1.23M ﹤0.01% 628
2025
Q4 		$30K Buy
+9,048
New +$23.5K ﹤0.01% 860
2025
Q3 		– Sell
-2,750,200
Closed -$1.97M – 904
2025
Q2 		$1.97M Sell
2,750,200
-1,247,601
-31% -$979K ﹤0.01% 557
2025
Q1 		$5.88M Sell
3,997,801
-83,700
-2% -$199K 0.01% 460
2024
Q4 		$18.1M Sell
4,081,501
-970,100
-19% -$3.94M 0.04% 329
2024
Q3 		$20.8M Sell
5,051,601
-1,019,900
-17% -$5.48M 0.04% 312
2024
Q2 		$39.6M Sell
6,071,501
-79,500
-1% -$562K 0.09% 237
2024
Q1 		$53.6M Sell
6,151,001
-631,100
-9% -$7.66M 0.11% 210
2023
Q4 		$77.6M Sell
6,782,101
-382,108
-5% -$3.78M 0.17% 172
2023
Q3 		$69M Sell
7,164,209
-506,100
-7% -$4.96M 0.16% 177
2023
Q2 		$81.6M Buy
7,670,309
+92,600
+1% +$995K 0.18% 168
2023
Q1 		$79.7M Sell
7,577,709
-348,688
-4% -$3.91M 0.18% 163
2022
Q4 		$98.2M Buy
7,926,397
+12,177
+0.2% +$138K 0.22% 145
2022
Q3 		$82M Buy
7,914,220
+435,063
+6% +$4.93M 0.19% 153
2022
Q2 		$86.2M Buy
7,479,157
+71,827
+1% +$846K 0.19% 157
2022
Q1 		$93.2M Sell
7,407,330
-100,076
-1% -$1.15M 0.17% 161
2021
Q4 		$87.5M Sell
7,507,406
-304,821
-4% -$3.74M 0.16% 171
2021
Q3 		$102M Buy
7,812,227
+3,448,000
+79% +$44.6M 0.18% 155
2021
Q2 		$56.2M Buy
4,364,227
+3,390,228
+348% +$38.8M 0.1% 221
2021
Q1 		$10.9M Buy
+973,999
New +$10.3M 0.02% 454

Other funds holding IRWD

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Ritholtz Wealth Management
Ritholtz Wealth Management New York $6.96B AUM 24% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

LSV Asset Management's IRWD Position: Q3 2026 in Review

LSV Asset Management held its Ironwood Pharmaceuticals (IRWD) position steady in Q3 2026 at 308,271 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #646.

LSV Asset Management first reported a position in IRWD in Q1 2021 and has held it in 22 quarters since. The position peaked at $102M in Q3 2021. 112 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • LSV Asset Management held 308,271 shares of Ironwood Pharmaceuticals worth $1.22M as of Q3 2026.
  • LSV Asset Management left its Ironwood Pharmaceuticals share count unchanged in Q3 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of LSV Asset Management's portfolio in Q3 2026, its #646 holding.
  • LSV Asset Management first reported a position in Ironwood Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • LSV Asset Management's Ironwood Pharmaceuticals position peaked at $102M in Q3 2021.
  • 112 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on LSV Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.